Albion Investors

Albion Investors LLC, established in 1995 and headquartered in New York, is a private investment firm managing funds for institutional and family-office investors. It specializes in private equity and debt investments, focusing on lower middle-market companies. Albion invests in value-added distribution, specialty manufacturing, and business services sectors, typically committing between $3 million to $30 million in equity and debt. The firm seeks lead positions in micro-cap deals and co-investment opportunities, with a focus on companies in the Mid-Atlantic, North-East, and South-East regions of the Continental United States and Canada. Albion's principals invest their own capital in every lead transaction. The firm's primary investment vehicle is a mezzanine note, combining subordinated debt and equity participation. Albion aims to take majority or minority stakes and board seats in its portfolio companies.

Mark Arnold

Co-Founder and Managing Partner

Charles Gonzalez

Managing Director

Edina Leiher

Vice President, Operations and CCO

Basil Livanos

Managing Director

Alastair Tedford

Co-Founder and Managing Partner

Christine Vogt

Vice President

Robert Wake

Managing Director

3 past transactions

Helveta

Venture Round in 2010
Helveta Ltd develops technology products for the timber and food sectors. It offers The CI World platform, an interactive cartography application that provides auditable traceability, asset tracking, resource and forest use mapping, and chain of custody control for extended supply chains; and allows monitoring logging activities, and to export data points and associated icons to GIS products enabling the online sharing of maps among communities over the Web. The company serves growers, farm managers, agronomists, and buyers. Helveta Ltd was incorporated in 2004 and is based in Oxford, the United Kingdom with operations in Nigeria, the Central African Republic, the Republic of Congo, and Cameroon.

Xceleron

Venture Round in 2010
Xceleron, founded in 1997 in York, UK, and now headquartered in Germantown, Maryland, specializes in bioanalytical accelerator mass spectrometry (AMS) services for drug development. The company pioneered human microdose and microtracer techniques to assess the pharmacokinetics and metabolism of developmental drugs during Phase 0, Phase I, and Phase II/III clinical trials. By focusing on micro-dosing and pre-clinical evaluations, Xceleron effectively conducts intravenous pharmacokinetics, metabolite profiling, and mass balance investigations in humans. The company's expertise is particularly beneficial given the challenges posed by contemporary small molecules, which often exhibit low solubility and long half-lives, making early pharmacokinetic and metabolic characterization essential for cost-effective clinical advancement. Driven by a commitment to integrity and scientific collaboration, Xceleron aims to facilitate the rapid and affordable delivery of life-changing products to those in need.

Osterman Propane

Series C in 2008
Osterman Propane is a provider of propane gas utilities catering to residential, commercial, and industrial clients. Founded in New England, the company has a legacy of over fifty years in delivering efficient propane gas and heating services. It was formed from the merger of Bay State Propane and Northern Propane, both of which were longstanding affiliates of Bay State Gas and Northern Utilities. Osterman Propane focuses on delivering quality services at competitive prices, ensuring that its clients receive reliable energy solutions tailored to their needs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.